AIDS-related primary central nervous system lymphoma in Norway
Author Information
Author(s): Haldorsen Ingfrid S, Kråkenes Jostein, Goplen Anne K, Dunlop Oona, Mella Olav, Espeland Ansgar
Primary Institution: Haukeland University Hospital
Hypothesis
What is the incidence and outcome of AIDS-related primary central nervous system lymphoma (PCNSL) in Norway from 1989 to 2003?
Conclusion
The study confirms a decreasing incidence of AIDS-related PCNSL in Norway, highlighting the need for more aggressive diagnostics despite poor survival rates.
Supporting Evidence
- The absolute incidence rate of PCNSL among AIDS patients was 1.7 per 100 person-years.
- The lifetime risk of PCNSL in AIDS patients was found to be 5.5%.
- Median survival from the first symptom of PCNSL was 2.3 months.
Takeaway
This study looked at how many people in Norway got a type of brain cancer related to AIDS over 15 years, and found that fewer people are getting it now, but most still don't live long after being diagnosed.
Methodology
Patients were identified through chart reviews from national cancer and autopsy registries, and data on incidence rates were calculated using person-time techniques.
Potential Biases
The study may be biased due to the reliance on autopsy data for diagnosis, which could miss cases diagnosed while alive.
Limitations
The small sample size and the fact that most patients were diagnosed post-mortem limit the ability to assess prognostic factors.
Participant Demographics
{"gender":{"male":26,"female":3},"mean_age_at_diagnosis":39.0}
Statistical Information
P-Value
p<0.001
Confidence Interval
95%CI: 1.1–2.4
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website